Targacept (TRGT +0.5%) creates a team of execs led by Chairman Mark Skaletsky to run the...
Targacept (TRGT +0.5%) creates a team of execs led by Chairman Mark Skaletsky to run the biopharmaceutical company following the resignation of CEO Donald deBethizy after 12 years at the firm. Targacept laid off 65 workers in April in the wake of disappointing results for its TC-6987 diabetes and asthma drug in two mid-stage trials.
From other sites
at CNBC.com (Dec 13, 2011)
at CNBC.com (Nov 15, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs